Valuation: Medios AG

Market Cap 296M 337M 272M 254M 479M 32.06B 489M 3.28B 1.27B 15.73B 1.27B 1.24B 54.76B P/E 2026 *
10.9x
P/E 2027 * 8.69x
Enterprise Value 372M 424M 342M 319M 602M 40.28B 614M 4.12B 1.6B 19.77B 1.59B 1.56B 68.82B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day+0.17%
1 week-0.82%
Current month+0.33%
1 month-10.88%
3 months-2.73%
6 months-17.44%
Current year-16.30%
1 week 11.98
Extreme 11.98
12.38
1 month 11.8
Extreme 11.8
13.64
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap.
02-04Sell

Chief Executive Officer

13,638 0.0535%
01-22Buy

Executive/Senior Manager

4,000 0.0157%
19/08/24Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%-0.82%-1.62%-24.25% 338M
-1.31%+6.09%+52.76%+156.87% 1,070B
-0.33%+5.21%+62.61%+55.22% 611B
-0.56%+7.05%+32.35%+86.25% 445B
-3.05%+4.18%+31.11%+23.88% 329B
-1.74%-0.40%+33.19%+33.55% 290B
-1.25%+0.53%+27.68%+41.18% 287B
+2.99%+4.00%-26.09%-40.14% 213B
-0.71%+2.59%+24.10%+60.23% 195B
-0.95%+0.38%+12.45%+63.78% 157B
Average -0.55%+4.54%+24.85%+45.65% 359.66B
Weighted average by Cap. -0.84%+6.67%+38.37%+78.55%

Financials

2026 *2027 *
Net sales 2.08B 2.37B 1.92B 1.79B 3.37B 225B 3.44B 23.04B 8.93B 111B 8.9B 8.71B 385B 2.14B 2.44B 1.97B 1.83B 3.46B 232B 3.53B 23.67B 9.17B 114B 9.14B 8.95B 396B
Net income 27.56M 31.39M 25.36M 23.64M 44.58M 2.98B 45.48M 305M 118M 1.46B 118M 115M 5.1B 34.36M 39.13M 31.62M 29.47M 55.58M 3.72B 56.71M 380M 147M 1.83B 147M 144M 6.36B
Net Debt 76M 86.56M 69.96M 65.19M 123M 8.23B 125M 841M 326M 4.04B 325M 318M 14.06B 40.72M 46.38M 37.48M 34.93M 65.87M 4.41B 67.21M 451M 175M 2.16B 174M 170M 7.53B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
01/07/26 12.12 +0.33% 20,875
30/06/26 €12.08 -0.33% 26,862
29/06/26 €12.12 +0.33% 47,058
26/06/26 €12.08 -0.17% 18,791
25/06/26 €12.10 -0.98% 20,352
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.08EUR
Average target price
23.00EUR
Spread / Average Target
+90.40%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock